Published in Mol Microbiol on May 01, 1993
Identification and characterization of the eps (Exopolysaccharide) gene cluster from Streptococcus thermophilus Sfi6. J Bacteriol (1996) 2.52
The serotype of type Ia and III group B streptococci is determined by the polymerase gene within the polycistronic capsule operon. J Bacteriol (2000) 2.45
Nucleotide sequence analysis of genes essential for capsular polysaccharide biosynthesis in Streptococcus pneumoniae type 19F. Infect Immun (1994) 2.24
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest (2005) 2.07
Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J Bacteriol (1999) 1.95
C-terminal half of Salmonella enterica WbaP (RfbP) is the galactosyl-1-phosphate transferase domain catalyzing the first step of O-antigen synthesis. J Bacteriol (1996) 1.79
The capsule polysaccharide synthesis locus of streptococcus pneumoniae serotype 14: Identification of the glycosyl transferase gene cps14E. J Bacteriol (1996) 1.67
Effect of type III group B streptococcal capsular polysaccharide on invasion of respiratory epithelial cells. Infect Immun (1993) 1.63
Streptococcus suis serotype 2 interactions with human brain microvascular endothelial cells. Infect Immun (2000) 1.52
Impact of phosphorylation of specific residues in the tyrosine autokinase, Wzc, on its activity in assembly of group 1 capsules in Escherichia coli. J Bacteriol (2002) 1.47
Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect Immun (2001) 1.43
Genotyping of the capsule gene cluster (cps) in nontypeable group B streptococci reveals two major cps allelic variants of serotypes III and VII. J Clin Microbiol (2000) 1.37
A novel streptococcal surface protease promotes virulence, resistance to opsonophagocytosis, and cleavage of human fibrinogen. J Clin Invest (2003) 1.36
Molecular characterization of type-specific capsular polysaccharide biosynthesis genes of Streptococcus agalactiae type Ia. J Bacteriol (1999) 1.32
A novel gene required for rhamnose-glucose polysaccharide synthesis in Streptococcus mutans. J Bacteriol (1999) 1.26
Cell growth rate regulates expression of group B Streptococcus type III capsular polysaccharide. Infect Immun (1996) 1.24
Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis. Infect Immun (2004) 1.20
Group B streptococci and other gram-positive cocci bind to cytokeratin 8. Infect Immun (2000) 1.20
Characterization of group B streptococcal invasion of human chorion and amnion epithelial cells In vitro. Infect Immun (1998) 1.19
Capsular polysaccharide production in Enterococcus faecalis and contribution of CpsF to capsule serospecificity. J Bacteriol (2009) 1.17
Exopolysaccharide biosynthesis in Lactococcus lactis NIZO B40: functional analysis of the glycosyltransferase genes involved in synthesis of the polysaccharide backbone. J Bacteriol (1999) 1.13
DNA polymorphism and molecular subtyping of the capsular gene cluster of group B streptococcus. J Clin Microbiol (2005) 1.11
Tyrosine phosphorylation and bacterial virulence. Int J Oral Sci (2012) 1.11
Linkage of genes essential for synthesis of a polysaccharide capsule in Sphingomonas strain S88. J Bacteriol (1996) 1.11
Mechanism of bacitracin resistance in gram-negative bacteria that synthesize exopolysaccharides. J Bacteriol (1994) 1.09
Analysis of a Coxiella burnetti gene product that activates capsule synthesis in Escherichia coli: requirement for the heat shock chaperone DnaK and the two-component regulator RcsC. J Bacteriol (1995) 1.09
CpsE from type 2 Streptococcus pneumoniae catalyzes the reversible addition of glucose-1-phosphate to a polyprenyl phosphate acceptor, initiating type 2 capsule repeat unit formation. J Bacteriol (2005) 1.08
Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing. Infect Immun (1995) 1.07
Novel Aeromonas hydrophila PPD134/91 genes involved in O-antigen and capsule biosynthesis. Infect Immun (2002) 1.06
Sialylation of group B streptococcal capsular polysaccharide is mediated by cpsK and is required for optimal capsule polymerization and expression. J Bacteriol (2005) 1.06
Effects of complement regulators bound to Escherichia coli K1 and Group B Streptococcus on the interaction with host cells. Immunology (2007) 1.05
Streptococcus iniae capsule impairs phagocytic clearance and contributes to virulence in fish. J Bacteriol (2006) 1.00
The CovS/CovR acid response regulator is required for intracellular survival of group B Streptococcus in macrophages. Infect Immun (2012) 0.98
Microbial protein-tyrosine kinases. J Biol Chem (2014) 0.98
Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion. Infect Immun (2009) 0.96
Acquisition of factor H by a novel surface protein on group B Streptococcus promotes complement degradation. FASEB J (2009) 0.93
L-Ficolin/mannose-binding lectin-associated serine protease complexes bind to group B streptococci primarily through N-acetylneuraminic acid of capsular polysaccharide and activate the complement pathway. Infect Immun (2007) 0.92
The streptococcal Blr and Slr proteins define a family of surface proteins with leucine-rich repeats: camouflaging by other surface structures. J Bacteriol (2006) 0.92
Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine. Infect Immun (1994) 0.89
Chemical inhibition of bacterial protein tyrosine phosphatase suppresses capsule production. PLoS One (2012) 0.82
SecA localization and SecA-dependent secretion occurs at new division septa in group B Streptococcus. PLoS One (2013) 0.80
Chloramphenicol is a substrate for a novel nitroreductase pathway in Haemophilus influenzae. Antimicrob Agents Chemother (2007) 0.80
Isolation and nucleotide sequence of the GDP-mannose:cellobiosyl-diphosphopolyprenol alpha-mannosyltransferase gene from Acetobacter xylinum. J Bacteriol (1996) 0.79
Group B Streptococcus induces a caspase-dependent apoptosis in fetal rat lung interstitium. Microb Pathog (2013) 0.78
The Cell Wall Teichuronic Acid Synthetase (TUAS) Is an Enzyme Complex Located in the Cytoplasmic Membrane of Micrococcus luteus. Biochem Res Int (2010) 0.77
Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD. J Biol Chem (2015) 0.76
Upregulated expression of the cDNA fragment possibly related to the virulence of Acanthamoeba culbertsoni. Korean J Parasitol (1999) 0.76
Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A (1987) 3.99
Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol Microbiol (1998) 3.84
Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect Immun (1992) 2.73
Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest (1996) 2.57
Molecular analysis of the role of the group A streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human invasive soft-tissue infection. J Clin Invest (1998) 2.47
Structure and immunochemistry of an oligosaccharide repeating unit of the capsular polysaccharide of type III group B Streptococcus. A revised structure for the type III group B streptococcal polysaccharide antigen. J Biol Chem (1987) 2.35
Functional analysis in type Ia group B Streptococcus of a cluster of genes involved in extracellular polysaccharide production by diverse species of streptococci. J Biol Chem (2001) 2.30
Relative contributions of hyaluronic acid capsule and M protein to virulence in a mucoid strain of the group A Streptococcus. Infect Immun (1997) 2.13
Immune response to type III group B streptococcal polysaccharide-tetanus toxoid conjugate vaccine. J Clin Invest (1996) 2.05
The changing spectrum of group B streptococcal disease. N Engl J Med (1993) 1.94
Hyaluronic acid capsule modulates M protein-mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest (1998) 1.87
IS861, a group B streptococcal insertion sequence related to IS150 and IS3 of Escherichia coli. J Bacteriol (1989) 1.80
Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun (1996) 1.79
Group A Streptococcus tissue invasion by CD44-mediated cell signalling. Nature (2001) 1.76
Tn916 delta E: a Tn916 transposon derivative expressing erythromycin resistance. Plasmid (1988) 1.65
Reduction of incorrect antibiotic dosing through a structured educational order form. Arch Intern Med (1988) 1.59
Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun (1992) 1.56
Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun (1994) 1.53
Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol (2000) 1.49
Effects of chain length on the immunogenicity in rabbits of group B Streptococcus type III oligosaccharide-tetanus toxoid conjugates. J Clin Invest (1992) 1.45
Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression. Infect Immun (1989) 1.38
Structure of the has operon promoter and regulation of hyaluronic acid capsule expression in group A Streptococcus. Mol Microbiol (1998) 1.30
Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. J Infect Dis (1999) 1.30
CD44 as a receptor for colonization of the pharynx by group A Streptococcus. J Clin Invest (2000) 1.30
Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect Immun (1992) 1.27
Molecular analysis of the capsule gene region of group A Streptococcus: the hasAB genes are sufficient for capsule expression. J Bacteriol (1998) 1.26
Characterization of the linkage between the type III capsular polysaccharide and the bacterial cell wall of group B Streptococcus. J Biol Chem (2000) 1.21
An oligosaccharide-tetanus toxoid conjugate vaccine against type III group B Streptococcus. J Biol Chem (1990) 1.18
Characterization of cpsF and its product CMP-N-acetylneuraminic acid synthetase, a group B streptococcal enzyme that can function in K1 capsular polysaccharide biosynthesis in Escherichia coli. Mol Microbiol (1996) 1.10
Regulation of capsule gene expression by group A Streptococcus during pharyngeal colonization and invasive infection. Mol Microbiol (2001) 1.10
Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides. J Immunol (1985) 1.07
Absence of a cysteine protease effect on bacterial virulence in two murine models of human invasive group A streptococcal infection. Infect Immun (2001) 1.06
Group B streptococcal opacity variants. J Bacteriol (1992) 1.05
Hormones, receptors, and cyclic AMP: their role in target cell refractoriness. Curr Top Cell Regul (1980) 1.00
Differences between agonist and antagonist binding following beta-adrenergic receptor desensitization. J Biol Chem (1978) 0.99
Capsular polysaccharide regulates neutrophil complement receptor interactions with type III group B streptococci. Infect Immun (1993) 0.98
Tsukamurella paurometabolum: a novel pathogen causing catheter-related bacteremia in patients with cancer. Clin Infect Dis (1992) 0.96
Role of complement component C1q in the IgG-independent opsonophagocytosis of group B streptococcus. J Immunol (1999) 0.95
Selective alteration in high affinity agonist binding: a mechanism of beta-adrenergic receptor desensitization. Mol Pharmacol (1979) 0.90
Cloning, sequence analysis and expression of the group A streptococcal guaB gene encoding inosine monophosphate dehydrogenase. Gene (1995) 0.89
Molecular analysis of two group B streptococcal virulence factors. Semin Perinatol (1990) 0.89
Functional activity of antibodies to the group B polysaccharide of group B streptococci elicited by a polysaccharide-protein conjugate vaccine. Infect Immun (1994) 0.89
Characterization of CMP-N-acetylneuraminic acid synthetase of group B streptococci. J Bacteriol (1994) 0.87
Molecular size affects antigenicity of type III, group B Streptococcus capsular polysaccharide. Trans Assoc Am Physicians (1985) 0.83
Characterization of the capsular polysaccharide genes of group B streptococci. Dev Biol Stand (1995) 0.83
Hyaluronic acid capsule modulates interactions of group A streptococci with human epidermal keratinocytes. Adv Exp Med Biol (1997) 0.80
Effect of hospitalwide change in clindamycin dosing schedule on clinical outcome. Rev Infect Dis (1989) 0.79
Glycolipid intermediates in biosynthesis of group B streptococcal capsular polysaccharide. Adv Exp Med Biol (1997) 0.77
Correct structure of repeating unit of group B Streptococcus type III capsular polysaccharide. J Infect Dis (1990) 0.77
Human granulocytic ehrlichiosis presenting as facial diplegia in a 42-year-old woman. Clin Infect Dis (2000) 0.76
Measurement of human antibodies to type III group B Streptococcus. Infect Immun (1999) 0.76
Pseudoinfection due to Tsukamurella paurometabolum. Clin Infect Dis (1992) 0.75
Regulation of hyaluronic acid capsule production by the has operon promoter in group A streptococci. Adv Exp Med Biol (1997) 0.75
Identification of a gene similar to ABC transporters near the capsule synthesis region of the group A streptococcal chromosome. Dev Biol Stand (1995) 0.75
Role of complement and complement receptor C1qR in the antibody-independent killing of group B streptococcus. Adv Exp Med Biol (1997) 0.75